Page last updated: 2024-10-18

dihydroxyphenylalanine and Cancer of Parathyroid

dihydroxyphenylalanine has been researched along with Cancer of Parathyroid in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research Excerpts

ExcerptRelevanceReference
"Preoperative localization of parathyroid adenomas (PA) can shorten operation time and improve curative rate; it becomes especially important in minimally invasive surgical techniques."1.33PET with 18F-DOPA in the imaging of parathyroid adenoma in patients with primary hyperparathyroidism. A pilot study. ( Brink, I; Hoegerle, S; Lange-Nolde, A; Moser, E; Reincke, M; Slawik, M; Zajic, T, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lange-Nolde, A1
Zajic, T1
Slawik, M1
Brink, I1
Reincke, M1
Moser, E1
Hoegerle, S1

Other Studies

1 other study available for dihydroxyphenylalanine and Cancer of Parathyroid

ArticleYear
PET with 18F-DOPA in the imaging of parathyroid adenoma in patients with primary hyperparathyroidism. A pilot study.
    Nuklearmedizin. Nuclear medicine, 2006, Volume: 45, Issue:5

    Topics: Adenoma; Aged; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Hyperparathyroidism; Middle A

2006